Literature DB >> 20484160

Accessibility of chewing tobacco products in England.

J M Longman1, C Pritchard, A McNeill, J Csikar, R E Croucher.   

Abstract

BACKGROUND: The carcinogenicity of chewing tobacco is well established. It is predominantly used by the South Asian community in England. Little is known about the accessibility of the products available for use in England.
METHODS: Wards with high proportions or numbers of residents from the South Asian community were identified using 2001 Census data. Within each ward product purchasers identified retail outlets and purchased chewing tobacco products from them.
RESULTS: Chewing tobacco products were found in a broad variety of premises in all but one ward, and were easily accessible. Ninety-eight products were identified and purchased with a mean price of pound1.82. Of the ninety four pre-packaged products purchased only 15% (95% CI: 8%, 22%) complied with legal health warning requirements.
CONCLUSION: The study indicates the need to improve compliance with legal controls and enforcement to protect the South Asian community from health risks associated with chewing tobacco products.

Entities:  

Mesh:

Year:  2010        PMID: 20484160     DOI: 10.1093/pubmed/fdq035

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  12 in total

1.  Availability, accessibility and promotion of smokeless tobacco in a low-income area of Mumbai.

Authors:  Jean J Schensul; Saritha Nair; Sameena Bilgi; Ellen Cromley; Vaishali Kadam; Sunitha D Mello; Balaiah Donta
Journal:  Tob Control       Date:  2012-03-02       Impact factor: 7.552

2.  Surveillance of Tobacco Use Among South Asians in the US: Are We Underestimating Prevalence?

Authors:  Michelle T Bover Manderski; Michael B Steinberg; Kimberly N Rahi; Smita C Banerjee; Cristine D Delnevo
Journal:  J Community Health       Date:  2016-12

3.  Social and cultural influences on tobacco-related health disparities among South Asians in the USA.

Authors:  Arnab Mukherjea; Patricia A Morgan; Lonnie R Snowden; Pamela M Ling; Susan L Ivey
Journal:  Tob Control       Date:  2011-06-27       Impact factor: 7.552

4.  Concordance of Advertised Cigarette Prices with Purchase Receipts in the United States.

Authors:  Nina C Schleicher; Trent O Johnson; Heather D'Angelo; Douglas A Luke; Kurt M Ribisl; Lisa Henriksen
Journal:  Tob Regul Sci       Date:  2018-05

Review 5.  A systematic review of store audit methods for assessing tobacco marketing and products at the point of sale.

Authors:  Joseph G L Lee; Lisa Henriksen; Allison E Myers; Amanda L Dauphinee; Kurt M Ribisl
Journal:  Tob Control       Date:  2013-01-15       Impact factor: 7.552

6.  Psychological predictors of male smokeless tobacco use initiation and cessation: a 16-year longitudinal study.

Authors:  Leela R Holman; Jonathan B Bricker; Bryan A Comstock
Journal:  Addiction       Date:  2013-04-04       Impact factor: 6.526

7.  Factors associated with dental and medical care attendance in UK resident Yemeni khat chewers: a cross sectional study.

Authors:  Saba Kassim; Ray Croucher
Journal:  BMC Public Health       Date:  2012-06-27       Impact factor: 3.295

8.  Before the ban--an exploratory study of a local khat market in East London, U.K.

Authors:  Saba Kassim; Asha Dalsania; Johan Nordgren; Axel Klein; Josh Hulbert
Journal:  Harm Reduct J       Date:  2015-06-12

9.  Point-of-sale tobacco advertising in Beirut, Lebanon following a national advertising ban.

Authors:  Ramzi G Salloum; Rima T Nakkash; Allison E Myers; Kathryn A Wood; Kurt M Ribisl
Journal:  BMC Public Health       Date:  2013-06-03       Impact factor: 3.295

10.  Behaviour change intervention for smokeless tobacco cessation: its development, feasibility and fidelity testing in Pakistan and in the UK.

Authors:  Kamran Siddiqi; Omara Dogar; Rukhsana Rashid; Cath Jackson; Ian Kellar; Nancy O'Neill; Maryam Hassan; Furqan Ahmed; Muhammad Irfan; Heather Thomson; Javaid Khan
Journal:  BMC Public Health       Date:  2016-06-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.